Helen M. Thackray

VP Clinical Development, CMO, CRESCENT BIOPHARMA, INC.

Companies

BioCryst PharmaceuticalsChief R&D Officer Apr 2, 2021 to now¹
ImmunoGen Inc.Board member Sep 23, 2021 to Feb 12, 2024²
BioCryst PharmaceuticalsBoard member Sep 24, 2019 to Apr 2, 2021³
CRESCENT BIOPHARMA, INC.VP Clinical Development, CMO Jan 9, 2014 to Jan 22, 2021⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 31, 2025Shares withheld for tax 7,525 shares at $7.50 of BioCryst Pharmaceuticals⁵
Dec 19, 2024Shares withheld for tax 6,096 shares at $7.39 of BioCryst Pharmaceuticals⁷
Dec 19, 2024Granted 125,950 shares of BioCryst Pharmaceuticals⁷
Dec 14, 2024Shares withheld for tax 7,150 shares at $7.53 of BioCryst Pharmaceuticals⁸
May 14, 2024Bought 30,000 shares at $5.86 of BioCryst Pharmaceuticals⁹
Mar 31, 2024Shares withheld for tax 7,525 shares at $5.08 of BioCryst Pharmaceuticals¹⁰
Feb 12, 2024Returned to company 3,074 shares of ImmunoGen Inc.⁶
Dec 29, 2023Granted 252 shares at $29.65 of ImmunoGen Inc.¹¹
Dec 19, 2023Shares withheld for tax 5,580 shares at $6.05 of BioCryst Pharmaceuticals¹²
Dec 14, 2023Shares withheld for tax 3,031 shares at $6.43 of BioCryst Pharmaceuticals¹³
Dec 14, 2023Granted 51,000 shares of BioCryst Pharmaceuticals¹³
Sep 29, 2023Granted 472 shares at $15.87 of ImmunoGen Inc.¹⁴
Jun 30, 2023Granted 397 shares at $18.87 of ImmunoGen Inc.¹⁵
Apr 3, 2023Sold 7,000 shares at $8.29 of BioCryst Pharmaceuticals¹⁶
Mar 31, 2023Granted 1,953 shares at $3.84 of ImmunoGen Inc.¹⁷
Dec 19, 2022Granted 81,000 shares of BioCryst Pharmaceuticals¹⁸
Dec 15, 2022Sold 3,125 shares at $10.89 of BioCryst Pharmaceuticals¹⁹
Apr 1, 2022Sold 7,600 shares at $16.20 of BioCryst Pharmaceuticals²⁰
Dec 14, 2021Granted 44,000 shares of BioCryst Pharmaceuticals²¹

The numbers on this page point here. Each one links to the record it came from.